Given the low frequency of copy number variants (CNVs) in these tumor genomes, the height and the focal nature of the MDM2 and the 2q36.3 amplicon suggest they were highly selected during the clinical history of this refractory TGCT. Here, MDM2 is linked to neoplasm.